{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:37:12Z","timestamp":1784734632885,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>We aimed to assess the impact of hypoglycemia in ST-elevation myocardial infarction (STEMI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Hypoglycemia increases the risk of mortality in patients with diabetes and high cardiovascular risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used the National Inpatient Sample (2005\u20132017) database to identify adult patients with STEMI as the primary diagnosis. The secondary diagnosis was hypoglycemia. We compared cardiovascular and socio-economic outcomes between STEMI patients with and without hypoglycemia and assessed temporal trends.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Hypoglycemia tends to complicate 0.17% of all cases hospitalized for STEMI. The mean age (\u00b1SD) of STEMI patients hospitalized with hypoglycemia decreased from 67 \u00b1 15 in 2005 to 63 \u00b1 12 in 2017 (<jats:italic>p<\/jats:italic> = 0.046). Mortality was stable with time, but the prevalence of ventricular tachycardia, ventricular fibrillation, acute renal failure, cardiogenic shock, total charges, and length of stay (LOS) increased with time (<jats:italic>p<\/jats:italic> &amp;lt; 0.05 for all). Compared to non-hypoglycemic patients, those who developed hypoglycemia were older and more likely to be black; only 6.7% had diabetes compared to 28.5% of STEMI patients (<jats:italic>p<\/jats:italic> = 0.001). Cardiovascular events were more likely to occur in hypoglycemia: mortality risk increased by almost 2.5-fold (adjusted OR = 2.625 [2.095\u20133.289]). There was a higher incidence of cardiogenic shock (adjusted OR = 1.718 [1.387\u20132.127]), atrial fibrillation (adjusted OR = 1.284 [1.025\u20131.607]), ventricular fibrillation (adjusted OR = 1.799 [1.406\u20132.301]), and acute renal failure (adjusted OR = 2.355 [1.902\u20132.917]). Patients who developed hypoglycemia were less likely to have PCI (OR = 0.596 [0.491\u20130.722]) but more likely to have CABG (OR = 1.792 [1.391\u20132.308]). They also had a longer in-hospital stay and higher charges\/stay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Hypoglycemia is a rare event in patients hospitalized with STEMI. However, it was found to have higher odds of mortality, arrhythmias, and other comorbidities, irrespective of diabetes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.940035","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T04:43:20Z","timestamp":1665377000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Hypoglycemia is associated with a higher risk of mortality and arrhythmias in ST-elevation myocardial infarction, irrespective of diabetes"],"prefix":"10.3389","volume":"9","author":[{"given":"Basel","family":"Humos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyad","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha","family":"Dargham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassim","family":"Al Suwaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Jneid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Abi Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.693879","article-title":"Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study.","volume":"119","author":"Myerson","year":"2009","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1001\/jama.2011.1654","article-title":"Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction.","volume":"306","author":"Canto","year":"2011","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7839101","article-title":"Macrovascular complications in patients with diabetes and prediabetes.","volume":"2017","author":"Huang","year":"2017","journal-title":"Biomed Res Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1210\/jc.2012-1364","article-title":"Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction.","volume":"97","author":"Marfella","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-020-01339-x","article-title":"Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cardiovasc Disord."},{"key":"B6","year":"2019","journal-title":"Healthcare Cost and Utilization Project (HCUP)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","article-title":"National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.","volume":"174","author":"Lipska","year":"2014","journal-title":"JAMA Intern Med."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-018-0357-y","article-title":"Impact of acute diabetes decompensation on outcomes of diabetic patients admitted with ST-elevation myocardial infarction.","volume":"10","author":"Issa","year":"2018","journal-title":"Diabetol Metab Syndr."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.004971","article-title":"In-hospital management and outcomes after ST-segment-elevation myocardial infarction in medicaid beneficiaries compared with privately insured individuals.","volume":"12","author":"Patel","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.105.594929","article-title":"Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models.","volume":"115","author":"Zou","year":"2007","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/cc10322","article-title":"Mild hypoglycemia is independently associated with increased mortality in the critically ill.","volume":"15","author":"Krinsley","year":"2011","journal-title":"Crit Care."},{"key":"B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4065\/mcp.2009.0394","article-title":"Hypoglycemia and outcome in critically ill patients.","volume":"85","author":"Egi","year":"2010","journal-title":"Mayo Clin Proc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients.","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1302564","article-title":"A randomized trial of hyperglycemic control in pediatric intensive care.","volume":"370","author":"Macrae","year":"2014","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2337\/diacare.26.5.1485","article-title":"Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring.","volume":"26","author":"Desouza","year":"2003","journal-title":"Diabetes Care."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1111\/dom.13348","article-title":"Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: a systematic review and meta-analysis.","volume":"20","author":"Fitzpatrick","year":"2018","journal-title":"Diabetes Obes Metab."},{"key":"B17","first-page":"78","article-title":"Hypoglycaemia-induced ischaemic ECG changes.","volume":"23","author":"Markel","year":"1994","journal-title":"Presse Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/emj.13.5.357","article-title":"Silent myocardial infarction during hypoglycaemic coma.","volume":"13","author":"Saunders","year":"1996","journal-title":"J Accid Emerg Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0140-6736(81)90950-8","article-title":"Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association.","volume":"2","author":"Tunbridge","year":"1981","journal-title":"Lancet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/dme.13114","article-title":"Causes of death in childhood-onset type 1 diabetes: long-term follow-up.","volume":"34","author":"Gagnum","year":"2017","journal-title":"Diabet Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1093\/eurheartj\/eht332","article-title":"Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.","volume":"34","author":"Mellbin","year":"2013","journal-title":"Eur Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00125-017-4422-0","article-title":"DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.","volume":"61","author":"Pieber","year":"2018","journal-title":"Diabetologia."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e955","DOI":"10.1210\/clinem\/dgab794","article-title":"Severe hypoglycemia and incident heart failure among adults with type 2 diabetes.","volume":"107","author":"Echouffo-Tcheugui","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.2337\/dc20-S006","article-title":"6 Glycemic targets: standards of medical care in diabetes-2020.","volume":"43","year":"2020","journal-title":"Diabetes Care."},{"key":"B25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00003495-200565030-00005","article-title":"Oral antidiabetic agents: current role in type 2 diabetes mellitus.","volume":"65","author":"Krentz","year":"2005","journal-title":"Drugs."},{"key":"B27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes.","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.7326\/0003-4819-151-6-200909150-00137","article-title":"Systematic review: glucose control and cardiovascular disease in type 2 diabetes.","volume":"151","author":"Kelly","year":"2009","journal-title":"Ann Intern Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9257930","article-title":"The landscape of glucose-lowering therapy and cardiovascular outcomes: from barren land to metropolis.","volume":"2017","author":"Nasrallah","year":"2017","journal-title":"Biomed Res Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/2042098614523031","article-title":"Safety of dipeptidyl peptidase 4 inhibitors: a perspective review.","volume":"5","author":"Karagiannis","year":"2014","journal-title":"Ther Adv Drug Saf."},{"key":"B32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2265.2008.03510.x","article-title":"No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.","volume":"71","author":"Lerche","year":"2009","journal-title":"Clin Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2337\/dc08-1355","article-title":"Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.","volume":"32","author":"Nauck","year":"2009","journal-title":"Diabetes Care."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.2337\/dc20-0498","article-title":"Efficacy and safety of short- and long-acting glucagon-like peptide 1 receptor agonists on a background of basal insulin in type 2 diabetes: a meta-analysis.","volume":"43","author":"Huthmacher","year":"2020","journal-title":"Diabetes Care."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/ki.2010.512","article-title":"Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.","volume":"120","author":"List","year":"2011","journal-title":"Kidney Int Suppl."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death.","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","article-title":"Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.","volume":"7","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/CIRCULATIONAHA.110.992297","article-title":"Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans.","volume":"124","author":"Rana","year":"2011","journal-title":"Circulation."},{"key":"B39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/ATVBAHA.111.227389","article-title":"Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase.","volume":"32","author":"Wang","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jacc.2007.10.063","article-title":"Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.","volume":"51","author":"Setoguchi","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10741-020-10012-6","article-title":"Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample.","volume":"26","author":"Mekhaimar","year":"2021","journal-title":"Heart Fail Rev."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87320-w","article-title":"Mortality and socio-economic outcomes among patients hospitalized for stroke and diabetes in the US: a recent analysis from the National Inpatient Sample.","volume":"11","author":"Tabbalat","year":"2021","journal-title":"Sci Rep."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.844068","article-title":"Trends and outcomes of aortic valve replacement in patients with diabetes in the US.","volume":"9","author":"Khan","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001090","article-title":"In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000-2010.","volume":"3","author":"Ahmed","year":"2014","journal-title":"J Am Heart Assoc."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.803092","article-title":"Temporal trends in outcomes of st-elevation myocardial infarction patients with heart failure and diabetes.","volume":"13","author":"Ali","year":"2022","journal-title":"Front Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.109.866533","article-title":"Smoking, clopidogrel, and mortality in patients with established cardiovascular disease.","volume":"120","author":"Berger","year":"2009","journal-title":"Circulation."},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003370","article-title":"Smoker\u2019s paradox in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.","volume":"5","author":"Gupta","year":"2016","journal-title":"J Am Heart Assoc."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.940035\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T04:43:26Z","timestamp":1665377006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.940035\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":47,"alternative-id":["10.3389\/fcvm.2022.940035"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.940035","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"article-number":"940035"}}